NIASPAN 1000 MG EXTENDED RELEASE FILM COATED TABLETS

Nchi: Israeli

Lugha: Kiingereza

Chanzo: Ministry of Health

Viambatanisho vya kazi:

NIACIN 1000 MG

Inapatikana kutoka:

ABBOTT MEDICAL LABORATORIES LTD

ATC kanuni:

C04AC01

Dawa fomu:

FILM COATED TABLETS - EXTENDED RELEASE

Njia ya uendeshaji:

PER OS

Viwandani na:

ABBOTT LABORATORIES , USA

Kundi la matibabu:

NICOTINIC ACID

Matibabu dalili:

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. Niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.NIASPAN is indicated to reduce elevated TC, LDL-C, Apo B and TG levels, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia. 2.NIASPAN in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with NIASPAN, simvastatin, or lovastatin monotherapy is considered inadequate. 3.In patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.In patients with a history of coronary artery disease (CAD) and hyperlipidemia, n

Idhini ya tarehe:

2012-08-01